Bearing Point Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.55M Sell
29,677
-6,057
-17% -$1.68M 0.89% 40
2026
Q1
$10.6M Buy
35,734
+853
+2% +$253K 1.65% 16
2025
Q4
$9.53M Buy
34,881
+3,898
+13% +$1.06M 1.49% 17
2025
Q3
$8.37M Buy
30,983
+766
+3% +$208K 1.44% 19
2025
Q2
$8.33M Buy
30,217
+2,010
+7% +$547K 1.53% 16
2025
Q1
$7.48M Sell
28,207
-6,110
-18% -$1.51M 1.59% 15
2024
Q4
$7.97M Buy
+34,317
New +$7.89M 1.66% 15

Other funds holding CME

Bearing Point Capital's CME Position: Q2 2026 in Review

Bearing Point Capital reduced its CME Group (CME) stake by 17% in Q2 2026, selling an estimated $1.68M and leaving 29,677 shares worth $6.55M. The position accounts for 0.89% of the portfolio, ranked #40.

Bearing Point Capital first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.6M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bearing Point Capital held 29,677 shares of CME Group worth $6.55M as of Q2 2026.
  • Bearing Point Capital sold 6,057 CME Group shares in Q2 2026, an estimated $1.68M.
  • CME Group made up 0.89% of Bearing Point Capital's portfolio in Q2 2026, its #40 holding.
  • Bearing Point Capital first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Bearing Point Capital's CME Group position peaked at $10.6M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bearing Point Capital's 13F filing for Q2 2026, filed 11 Aug 2026.